NCT02355990View on ClinicalTrials.gov

Minimally Invasive Micro Sclerostomy First in Man Safety and Preliminary Performance Study

NACompletedINTERVENTIONAL
Enrollment

96

Participants

Timeline

Start Date

February 1, 2015

Primary Completion Date

January 1, 2019

Study Completion Date

December 15, 2020

Conditions
Primary Open Angle GlaucomaPigmentary GlaucomaPseudoexfoliative Glaucoma
Interventions
PROCEDURE

Minimally Invasive Micro Sclerostomy

Creation of a drainage channel of 50 - 100 microns (diameter) at the sclera-corneal junction and extending from the anterior chamber to the interface between the sclera and the conjunctiva (subconjuctival space).

Trial Locations (1)

Unknown

Goldschleger Eye Institute, The Chaim Sheba Medical Center, Tel Litwinsky

All Listed Sponsors
lead

Sanoculis Ltd

INDUSTRY

NCT02355990 - Minimally Invasive Micro Sclerostomy First in Man Safety and Preliminary Performance Study | Biotech Hunter | Biotech Hunter